Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vastarel MR - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Vastarel MR

Approved

STANDARD

Vastarel MR

Les Laboratoires Servier Industrie🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 9db7acc2723a8c0e
Company: Les Laboratoires Servier Industrie
Type: Standard

Approval Details

Approval Id: 9db7acc2723a8c0e
Drug Approval Philippines Name: Vastarel MR
Product Name: Vastarel MR
Registration Number: DR-XY27357
Brand Name: Vastarel MR
Generic Name: Trimetazidine
Dosage Form: Modified-Release Tablet
Dosage Strength: 35mg
Manufacturer: Les Laboratoires Servier Industrie
Importer: Zuellig Pharma Corporation
Distributor: Zuellig Pharma Corporation
Company Detail Path: /organization/les-laboratoires-servier-industrie
Issuance Date: 28 January 2022
Expiry Date: 15 March 2027
Classification: Prescription Drug (Rx)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

9db7acc2723a8c0e

Type

Standard

Back to Philippines FDA Approvals